Research Platform for Bleeding & Clotting Disease Research
The Bleeding & Clotting disease area focuses on understanding the mechanisms of blood coagulation and bleeding tendencies. Research in this field not only elucidates the pathology of hematological disorders but also guides the development of new drugs and the optimization of treatment strategies. By using animal models, particularly non-human primates (NHPs) with high similarity to humans, researchers can simulate human bleeding and clotting conditions, enabling effective drug validation and therapeutic testing. This area integrates clinical pathology, imaging technologies, and surgical techniques, providing a comprehensive platform for hematological research.
Why Use NHP for Bleeding & Clotting Disease Research Modeling
Non-human primates (NHPs) are ideal models for studying bleeding and clotting disorders due to their anatomical and genetic similarities to humans. They share a gyrencephalic brain structure and clinical endpoints with humans, along with a diverse genetic background that mirrors human populations. The biological targets in NHPs are identical to those in humans, making the research findings highly translatable, particularly for biomolecular drug development. These factors collectively make NHPs a valuable model for investigating the mechanisms and treatments of bleeding and clotting disorders.
Anatomical Similarity
NHPs possess a gyrencephalic brain structure similar to humans, which is crucial for accurately modeling the neurological aspects of bleeding and clotting disorders.
Clinical Endpoint Consistency
NHPs exhibit clinical endpoints identical to humans, making them a reliable model for studying the progression and treatment outcomes of bleeding and clotting conditions.
Genetic Diversity
The diverse genetic background of NHPs closely mirrors the human population, providing a relevant model for understanding the genetic factors influencing bleeding and clotting disorders.
Biological Target Similarity
The biological targets for treatments in NHPs are identical to those in humans, ensuring that research findings are directly translatable to human conditions.
Translatability of Research Outcomes
The structural and functional similarities between NHPs and humans ensure that the research outcomes, particularly for biomolecular drugs, are highly relevant and applicable to human medical treatments for bleeding and clotting disorders.
Superior Platform for Bleeding & Clotting Research at Prisys
Prisys Biotech offers an exceptional platform for Bleeding & Clotting research, featuring the following key elements:
Sophisticated Models & Pathology
Advanced models and comprehensive clinical pathology capabilities ensure accurate simulation and analysis of bleeding and clotting disorders.
Imaging Facilities
Sterile surgical units and advanced imaging technologies (CT, MRI, Doppler-ultrasound), along with an ICU for comprehensive post-surgical care.
Expert Team
A team of skilled professionals, including former physicians, supports the platform with high-quality imaging analysis and radiation intervention, enhancing the quality of bleeding and clotting research.
Bleeding & Clotting Disease Models
Bleeding Disorders:
Intracerebral hemorrhage (ICH)
Post-surgical or traumatic bleeding
Anemia-related bleeding
Clotting Disorders:
Thrombosis due to arteriovenous shunt (AV-shunt)
Middle cerebral artery occlusion (MCAO)
Pulmonary embolism (PE)
FAQ
What advantages do NHP models offer for studying bleeding and clotting disorders?
NHPs share structural and biological similarities with humans, including identical clinical endpoints and genetic diversity. These factors make NHPs ideal for studying bleeding and clotting disorders and for validating biomolecular drugs, ensuring translatable research outcomes.
What clinical pathology capabilities does Prisys offer for bleeding and clotting research?
Prisys provides comprehensive clinical pathology tools, including CBC analysis, biochemical assays, and various clotting tests such as APTT, PT, TT, fibrinogen levels, and D-dimer assays, offering detailed insights into coagulation processes.
What specialized bleeding and clotting models are available at Prisys?
Prisys offers a range of bleeding and clotting models, including refined bleeding models like forearm vein bleeding and advanced clotting models such as arteriovenous (AV) shunt and pulmonary embolization. These models enable simulation and study of various bleeding and clotting scenarios.
What facilities and technologies support bleeding and clotting research at Prisys?
Prisys boasts a 1000m² lab space designed to replicate a hospital environment, complete with sterile surgical units and advanced imaging technologies like CT, MRI, and Doppler-ultrasound. An intensive care unit is also available for comprehensive post-surgical care.